Wenyu Shi, Huayuan Zhu, Jianyong Li, Xiaoyan Xie, Xuzhang Lu, Lei Cao, Miao Sun, Yi Xia. "Polatuzumab vedotin combined with orelabrutinib and rituximab (PRO Regimen) as frontline therapy in elderly and frail patients with diffuse large B-cell lymphoma (DLBCL): Results from A phase II study." Blood, 2025. doi:10.1182/blood-2025-5477